Mục tiêu nghiên cứu: Xác định tỉ lệ rối loạn nhu động đại trực tràng bằng viên nang cản quang và một số yếu tố liên quan ở người bệnh […]

Cirrhosis and liver cancer are among the leading causes of death in Vietnam, with some of the highest incidence rates in the Asia-Pacific region. Early diagnosis plays a crucial role in treatment and improving the quality of life for patients. In a collective effort to address this challenge, M2BPGi – a blood biomarker test – promises a breakthrough in the early diagnosis of liver cancer and cirrhosis.

Gastrointestinal endoscopy is an advanced technique that helps detect and treat digestive diseases early, from ulcers to cancer, providing high effectiveness for patients and improving the quality of healthcare.